Armen Mardiros

Title: Armen Mardiros: Innovator in Cancer Immunotherapy

Introduction

Armen Mardiros is a prominent inventor based in Duarte, CA, known for his significant contributions to cancer immunotherapy. With a total of 5 patents, Mardiros has focused on developing innovative therapies that harness the power of the immune system to combat cancer.

Latest Patents

Mardiros's latest patents include groundbreaking work on CD70 binding molecules and methods of use thereof. This patent discloses anti-CD70 antibodies, antigen binding fragments, chimeric antigen receptors (CARs), and engineered T cell receptors (TCRs) that specifically bind to CD70. These innovations can be utilized in engineered TCR and CAR T cell therapies for treating patients suffering from various cancers, including multiple myeloma. Another notable patent involves CD123-specific chimeric antigen receptor redirected T cells and their methods of use. This family of CARs targets different epitopes on CD123 and has shown promising results in redirecting T cell specificity to effectively combat acute myeloid leukemia (AML).

Career Highlights

Throughout his career, Mardiros has worked with esteemed organizations such as City of Hope and Kite Pharma, Inc. His work has significantly advanced the field of immunotherapy, particularly in developing CAR T cell therapies that have the potential to improve patient outcomes in cancer treatment.

Collaborations

Mardiros has collaborated with notable professionals in the field, including Stephen J. Forman and Christine E. Brown. These collaborations have further enriched his research and development efforts in cancer immunotherapy.

Conclusion

Armen Mardiros is a key figure in the field of cancer immunotherapy, with a focus on innovative therapies that utilize the immune system to fight cancer. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment.